Description and Survival of Stage I and II Lung Cancer Patients

被引:3
|
作者
Perez-Martinez, Olaia [1 ]
Vidal-Garcia, Iria [2 ]
Montero-Martinez, Carmen [2 ]
Provencio, Mariano [3 ]
Ruano-Ravina, Alberto [4 ,5 ]
机构
[1] Complejo Hosp Univ A Coruna, Serv Med Prevent, La Coruna, Spain
[2] Complejo Hosp Univ A Coruna, Serv Neumol, La Coruna, Spain
[3] Hosp Univ Puerta de Hierro Majadahonda, Serv Oncol, Majadahonda, Spain
[4] Univ Santiago de Compostela, Dept Med Prevent & Salud Publ, Santiago De Compostela, Spain
[5] CIBERESP, Madrid, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2018年 / 54卷 / 08期
关键词
Lung cancer; Survival; Cancer by histologic type; Epidemiology; Early diagnosis; MORTALITY; DIAGNOSIS; SPAIN;
D O I
10.1016/j.arbres.2018.02.007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: The objective of our study was to describe the characteristics of patients diagnosed with stage I and II lung cancer in the health area of A Corutia (Galicia) and to determine their overall survival according to certain variables. Methods: Retrospective case series in patients diagnosed between January 2011 and December 2015 with stage I and II primary lung cancer with a minimum follow-up of 18 months. Results: 158 patients were included, 99 at stage 1, with a median age of 69 years [range 20-90], predominantly men (81%). Adenocarcinoma was the most common histology (52.9%), followed by epidermoid carcinoma (33.1%). Asymptomatic patients (35.9%) presented more frequently in stage I. Median survival was 57 months (95% Cl 48.1-65.9), with higher survival among women, patients under 70 years of age, and those who received surgical treatment. Conclusions: Early stage lung cancer in the health area of A Camila occurs predominantly in men, in advanced age, and with adenocarcinoma histology. Survival was greater among patients with stage I disease, women, individuals aged under 70 years, and those treated surgically. Despite early diagnosis, median survival was less than 5 years. (C) 2018 SEPAR Published by Elsevier Espaiia, S.L.U. All rights reserved.
引用
收藏
页码:420 / 426
页数:7
相关论文
共 50 条
  • [11] Stereotactic radiotherapy for stage I and II lung cancer: A study of 33 patients
    Champeaux-Orange, E.
    Wachter, T.
    Bouscayrol, H.
    Barillot, I.
    CANCER RADIOTHERAPIE, 2011, 15 (03): : 192 - 196
  • [12] Impact of Preoperative Pulmonary Function on Survival Following Lobectomy for Stage I and II Lung Cancer
    Grapatsas, K.
    Doerr, F.
    Oezkan, F.
    Baldes, N.
    Darwiche, K.
    Theegarten, D.
    Eberhardt, W.
    Gauler, T.
    Stuschke, M.
    Hautzel, H.
    Herrmann, K.
    Taube, C.
    Forsting, M.
    Schuler, M.
    Boeluekbas, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S531 - S531
  • [13] Results of the operation of lung cancer in stage I and II
    Wertzel, H.
    Riech, C.
    Burger, E.
    Conrad, C.
    Guschall, W. R.
    ONKOLOGIE, 2010, 33 : 131 - 131
  • [14] The impact of PET-based staging on survival of patients with stage I lung cancer
    Begum, M.
    Robinson, L.
    Sommers, E.
    Bepler, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [15] Postrecurrence survival in patients with stage I non-small cell lung cancer
    Nakagawa, Tatsuo
    Okumura, Norihito
    Ohata, Keiji
    Igai, Hitoshi
    Matsuoka, Tomoaki
    Kameyama, Kotaro
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 34 (03) : 499 - 504
  • [16] Management of Patients With Stage I Lung Cancer
    Bogart, Jeffrey A.
    Wallen, Jason
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (02) : 69 - +
  • [17] Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer
    Shen, JG
    Cheong, JH
    Hyung, WJ
    Kim, J
    Choi, SH
    Noh, SH
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (02) : 126 - 130
  • [18] Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer
    Domachevsky, L.
    Groshar, D.
    Galili, R.
    Saute, M.
    Bernstine, H.
    EUROPEAN RADIOLOGY, 2015, 25 (11) : 3361 - 3367
  • [19] Preoperative anemia decreases survival in patients with stage I and II non-small-cell lung cancer treated with surgery
    Yovino, S
    Kwok, Y
    Krasna, M
    Bangalore, M
    Suntharalingam, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S531 - S531
  • [20] Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer
    L. Domachevsky
    D. Groshar
    R. Galili
    M. Saute
    H. Bernstine
    European Radiology, 2015, 25 : 3361 - 3367